VARIATIONS OF ANTITUMOUR ANTIBODIES IN PATIENTS TREATED WITH TRANSFER FACTOR11The work in Paris was carried out thanks to grants from NATO (Grant No. 1242), the Ligue Nationale Française contre le Cancer, the FEGEFLUC and Laboratoires Roche.